Impact Of A Health Care Protocol For Patients Suffering Symptoms Of Mild Acute Viral Bronchiolitis On Early Release In The Emergency Department
NCT ID: NCT01091064
Last Updated: 2015-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE2
INTERVENTIONAL
2011-10-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that patients liberated from triage with mild acute viral bronchiolitis would have the same rate of office re-visits than those with mild acute bronchiolitis in the emergency department.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HYPERTONIC SALINE IN ACUTE VIRAL BRONCHIOLITIS: A RANDOMIZED CLINICAL TRIAL
NCT00729274
Inhaled Hypertonic Saline for Bronchiolitis
NCT02253576
Hypertonic Saline for Acute Bronchiolitis
NCT01247064
Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis
NCT06506474
Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis
NCT02834819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Increasing workload in the ED is a national worry after the last 20 years. Between October and April, this phenomena is seen each year due to cold and influenza season. From an economic perspective along with a lack in human resources, new strategies have to be implemented to reduce duration and costs in office visits in the emergency department. Since mild bronchiolitis does not require a specific treatment, we hypothesize that patients liberated from triage with mild acute viral bronchiolitis would have the same rate of office re-visits than those with mild acute bronchiolitis in the emergency department.
Our principal objective will be to compare between groups of infants with mild acute viral bronchiolitis the use of hospital resources within the fist 15 days after recruitment. Specific objectives will be to compare between the 2 groups the rate of office re-visit, or to the ED during the fist 15 days after recruitment, the severity of respiratory symptoms during re-visits, on follow up at 2-4 days, 6-8 days and 13-15 days, patient and parent satisfaction of the first visit and of follow up at 2-4 days, 6-8 days and 13-15 days.
This research project will have a rapid and direct effect on quality of health care in infants with acute viral bronchiolitis and their parents, as well as important repercussions on the workload in the waiting rooms of EDs allowing physicians to concentrate on other patients are in need of a rapid attention. This project will be carried on in two high concentration specialized hospitals in the province of Quebec, Canada.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early depart
Patients who will be liberated at triage with mild acute viral bronchiolitis
Randomization early depart
Patients will be randomized to either an early depart or for being seen by a physician.
Medical visit group
Patients with acute viral bronchiolitis who will wait to be seen by the physician
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Randomization early depart
Patients will be randomized to either an early depart or for being seen by a physician.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Infants born before 30 weeks gestation.
* Infants' weight \< 5 kg.
* Infants with a dehydration score of more or equal to 1.
* Yale score \> 10.
* Infants with chronic pulmonary, cardiovascular or neuromuscular disease.
* Infants with primary or secondary immunodeficiencies.
* Patients with the antecedent of wheezing.
* Need of any ventilatory support.
* Patients in whom the diagnosis of acute viral bronchiolitis is not precise.
* Patients in whose parents refuse to sign the consent formulary or not willing to participate.
3 Months
12 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dre Chantal Guimont
Professeur
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laval University Hospital Center
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20636
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.